Resveratrol protects left ventricle by increasing adenylate kinase 1 and isocitrate dehydrogenase activities in rats with myocardial infarction

Chinese Journal of Physiology

Volumn 54, Issue 6, 2011, Pages 406-412

  Lin, Jeng Feng ^a,b   Wu, Semon ^c   Huang, Shiang Suo ^e   Lu, Bo Yi ^e   Lin, Su Man ^d   Tsai, Shen Kou ^f,g  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CHINESE CULTURE UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adenylate kinase 1; Isocitrate dehydrogenase; Myocardial infarction; Resveratrol

Indexed keywords

ADENYLATE KINASE; ADENYLATE KINASE 1; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE (NADP); REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INDUCTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84455174542     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM097     Document Type: Article

References (28)

1. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R. and Sinclair, D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006.
2. Braunwald, E. Biomarkers in heart failure. N. Engl. J. Med. 358: 2148-2159, 2008.
3. Chen, C.J., Yu, W., Fu, Y.C., Wang, X., Li, J.L. and Wang, W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 378: 389-393, 2009.
4. Chen, Y.R., Yi, F.F., Li, X.Y., Wang, C.Y., Chen, L., Yang, X.C., Su, P.X. and Cai, J.R. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc. Drugs Ther. 22: 479-485, 2008.
5. Dargie, H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 357: 1385-1390, 2001.
6. Dzeja, P.P., Bast, P., Pucar, D., Wieringa, B. and Terzic, A. Defective metabolic signaling in adenylate kinase AK1 gene knockout hearts compromises post-ischemic coronary reflow. J. Biol. Chem. 282: 31366-31372, 2007.
7. Dzeja, P.P. and Terzic, A. Phosphotransfer networks and cellular energetics. J. Exp. Biol. 206: 2039-2047, 2003.
8. Dzeja, P.P., Vitkevicius, K.T., Redfield, M.M., Burnett, J.C. and Terzic, A. Adenylate kinase catalyzed phosphotransfer in the myocardium: Increased contribution in heart failure. Circ. Res. 84: 1137-1143, 1999.
9. Frankel, E.N., Waterhouse, A.L. and Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104, 1993.
10. Fukuda, S., Kaga, S., Zhan, L., Bagchi, D., Das, D.K., Bertelli, A. and Maulik, N. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor flk-1. Cell. Biochem. Biophys. 44: 43-49, 2006.
11. He, S., Jiang, L., Wu, B., Pan, Y. and Sun, C. Pallidol, a resveratrol dimer from red wine, is a selective singlet oxygen quencher. Biochem. Biophys. Res. Commun. 379: 283-287, 2009.
12. Hung, L.M., Su, M.J. and Chen, J.K. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms, Free Radic. Biol. Med. 36: 774-781, 2004.
13. Imamura, G., Bertelli, A.A., Bertelli, A., Otani, H., Maulik, N. and Das, D.K. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am. J. Physiol. Heart Circ. Physiol. 282: H1996-H2003, 2002.
14. + -dependent isocitrate dehydrogenase. J. Biol. Chem. 276: 16168-16176, 2001.
15. Koshland, D.E.Jr., Walsh, K. and LaPorte, D.C. Sensitivity of metabolic fluxes to covalent control. Curr. Top. Cell Regul. 27: 13-22, 1985.
16. Lin, J.F., Lin, S.M., Chih, C.L., Nien, M.W., Su, H.H., Hu, B.R., Huang, S.S. and Tsai, S.K. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci. 83: 313-317, 2008.
17. McGregor, E. and Dunn, M.J. Proteomics of the heart: unraveling disease. Circ. Res. 98: 309-321, 2006.
18. Mizutani, K., Ikeda, K., Kawai, Y. and Yamori, Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 28: 55-59, 2001.
19. Pfeffer, M.A., Braunwald, E., Moye, L.A., Basta, L., Brown, E.J.Jr., Cuddy, T.E., Davis, B.R., Geltman, E.M., Goldman, S. and Flaker, G.C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327: 669-677, 1992.
20. Pfeffer, M.A., Pfeffer, J.M., Fishbein, M.C., Fletcher, P.J., Spadoro, J., Kloner, R.A. and Braunwald, E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
21. Pucar, D., Bast, P., Gumina, R.J., Lim, L., Drahl, C., Juranic, N., Macura, S., Janssen, E., Wieringa, B., Terzic, A. and Dzeja, P.P. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 283: H776-H782, 2002.
22. Richards, A.M., Nicholls, M.G., Espiner, E.A., Lainchbury, J.G., Troughton, R.W., Elliott, J., Frampton, C., Turner, J., Crozier, I.G. and Yandle, T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107: 2786-2792, 2003.
23. Sawicki, G., Leon, H., Sawicka, J., Sariahmetoglu, M., Schulze, C.J., Scott, P.G., Szczesna-Cordary, D. and Schulz, R. Degradation of myosin light chain in isolated rat hearts subjected to ischemiareperfusion injury: a new intracellular target for matrix metalloproteinase- 2. Circulation 112: 544-552, 2005.
24. Soleas, G.J., Diamandis, E.P. and Goldberg, D.M. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11: 287-313, 1997.
25. Velagaleti, R.S., Pencina, M.J., Murabito, J.M., Wang, T.J., Parikh, N.I., D'Agostino, R.B., Levy, D., Kannel, W.B. and Vasan, R.S. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118: 2057-2062, 2008.
26. Xu, Q., Hao, X., Yang, Q. and Si, L. Resveratrol prevents hyperglycemia- induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem. Biophys. Res. Commun. 388: 389-394, 2009.
27. + /NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox. Signal 10: 179-206, 2008.
28. Zeleznikar, R.J., Heyman, R.A., Graeff, R.M., Walseth, T.F., Dawis, S.M., Butz, E.A. and Goldberg, N.D. Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle. J. Biol. Chem. 265: 300-311, 1990.